Mydecine Innovations Group Inc.
MYCOF
$0.0045
-$0.0006-11.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.73M | -10.15M | -10.07M | -17.06M | -8.86M |
| Total Depreciation and Amortization | 0.00 | 900.00 | 3.40K | 7.30K | 13.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.65M | 5.56M | 5.47M | 10.10M | -1.05M |
| Change in Net Operating Assets | 5.79M | 5.26M | 4.65M | 4.80M | 6.12M |
| Cash from Operations | 716.00K | 663.90K | 58.70K | -2.15M | -3.77M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 18.80K | 388.50K | 360.80K |
| Cash from Investing | 0.00 | 0.00 | 18.80K | 388.50K | 360.80K |
| Total Debt Issued | 110.00K | 110.00K | 110.00K | 110.00K | 102.70K |
| Total Debt Repaid | -- | -- | -- | -- | -67.00K |
| Issuance of Common Stock | -- | 1.00K | 825.50K | 3.33M | 4.77M |
| Repurchase of Common Stock | -1.04M | -1.04M | -1.04M | -1.04M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -273.10K |
| Cash from Financing | -684.70K | -684.00K | -70.20K | 1.78M | 3.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -100.00 |
| Net Change in Cash | 31.30K | -20.00K | 7.40K | 19.70K | -52.60K |
